According to Pediatrix Medical Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.0843. At the end of 2021 the company had a P/E ratio of 17.8.
Year | P/E ratio | Change |
---|---|---|
2021 | 17.8 | -790.09% |
2020 | -2.58 | 67.4% |
2019 | -1.54 | -113.72% |
2018 | 11.2 | -27.74% |
2017 | 15.5 | -18.41% |
2016 | 19.0 | -4.17% |
2015 | 19.9 | -3.31% |
2014 | 20.5 | 7.7% |
2013 | 19.1 | 18.01% |
2012 | 16.2 | 1.61% |
2011 | 15.9 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
![]() Universal Health Services
UHS | 13.1 | 29.51% | ๐บ๐ธ USA |
![]() Community Health Systems
CYH | 1.29 | -87.22% | ๐บ๐ธ USA |
![]() Tenet Healthcare THC | 14.2 | 40.48% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.